KOD - CIK 0001468748
The table below shows Kodiak Sciences Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $182.37M | $126.09M | $206.30M | $267.59M | $217.34M | $107.39M |
| SG&A | $52.02M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $60.75M |
| $71.02M |
| $73.79M |
| $49.71M |
| $28.62M |
| Operating income | -$234.39M | -$186.85M | -$277.32M | -$341.38M | -$267.05M | -$136.01M |
| Income tax | $52.00K | $20.00K | $33.00K | $33.00K | $74.00K | $14.00K |
| Net income | -$229.97M | -$176.21M | -$260.49M | -$333.82M | -$266.99M | -$133.10M |
| EPS (diluted) | -$4.32 | -$3.35 | -$4.97 | -$6.39 | -$5.16 | -$2.91 |